Ellevest, Inc. Axonics, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$52.6 - $67.34 $1,683 - $2,154	-32 Reduced 40.0%	48 $2,000
Q4 2022 Feb 03, 2023	SELL	$59.56 - $76.6 $3,394 - $4,366	-57 Reduced 41.61%	80 $5,000
Q3 2022 Nov 02, 2022	BUY	$57.96 - $78.12 $5,216 - $7,030	90 Added 191.49%	137 $10,000
Q2 2022 Jul 18, 2022	BUY	$39.5 - $64.42 $1,659 - $2,705	42 Added 840.0%	47 $3,000
Q1 2022 Apr 19, 2022	BUY	$43.74 - $62.76 $87 - $125	2 Added 66.67%	5 $0
Q4 2021 Jan 24, 2022	BUY	$50.01 - $73.35 $150 - $220	3 New	3 $0

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.